<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>数字病理 on AI内参</title>
    <link>https://www.neican.ai/tags/%E6%95%B0%E5%AD%97%E7%97%85%E7%90%86/</link>
    <description>Recent content in 数字病理 on AI内参</description>
    <generator>Hugo</generator>
    <language>zh-cn</language>
    <lastBuildDate>Wed, 03 Sep 2025 11:40:04 +0800</lastBuildDate>
    <atom:link href="https://www.neican.ai/tags/%E6%95%B0%E5%AD%97%E7%97%85%E7%90%86/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>当算法遇上病理：PreciseDx如何在与癌症的赛跑中“切片”时间</title>
      <link>https://www.neican.ai/insights/precisedx-20250903114004737-0/</link>
      <pubDate>Wed, 03 Sep 2025 11:40:04 +0800</pubDate>
      <guid>https://www.neican.ai/insights/precisedx-20250903114004737-0/</guid>
      <description>PreciseDx凭借其独特的“AI+肿瘤形态学”技术，成功将乳腺癌复发风险评估时间大幅缩短、成本降低，并通过精准分层减少过度治疗，为患者赢得了宝贵的治疗窗口。其获得医疗巨头和产业资本的战略投资，并积极布局“临床验证－产业落地－学术引领”的生态合作网络，展现了AI在企业级医疗诊断领域巨大的商业化潜力和市场影响力，预示着传统病理诊断模式的深刻变革。</description>
    </item>
  </channel>
</rss>
